一次抗体と二次抗体-抗-エピトープタグ、免疫測定、Cas 9 » MonoRab™ ウサギモノクローナル抗体製品 » MonoRab™ Anti-Rituximab Antibody (137C6), mAb, Rabbit
MonoRab™ Anti-Rituximab Antibody (137C6), MAb, Rabbit

Anti-Rituximab Antibody (137C6), mAb, Rabbit (GenScript, A01942-40) binds with Rituximab. While the antibody does not recognize the human IgG Fc fragment (data not shown).
Coating antigen: Rituximab, 1 µg/ml.
Anti-Rituximab antibody (GenScript, A01942-40) dilution start from 1,000 ng/ml.
EC₅₀= 12.17 ng/ml.

MonoRab™ Anti-Rituximab Antibody (137C6), MAb, Rabbit

Standard curve of Rituximab Sandwich ELISA. The Rituximab Sandwich ELISA assay is developed by using Anti-Rituximab Antibody (137C6), mAb, Rabbit (GenScript, A01942-40) and Anti-Rituximab Antibody (194D7) [Biotin], mAb, Rabbit (GenScript, A01944-40) as capture and detection antibody, respectively.
The sensitivity of detecting Rituximab is about 30 pg/ml.

MonoRab™ Anti-Rituximab Antibody (137C6), mAb, Rabbit

The product is specific for Rituximab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01944-40, MonoRab™ Anti-Rituximab Antibody (194D7) [Biotin], mAb, Rabbit.
A01942
¥36,423.00

Ask us a question
Overview
Specificity The product is specific for Rituximab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01944-40, MonoRab™ Anti-Rituximab Antibody (194D7) [Biotin], mAb, Rabbit.
Host Species Rabbit
Immunogen Rituximab
Conjugate Unconjugated

Applications
Working concentrations for specific applications should be determined by the investigators. The appropriate concentration may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
ELISA 0.01-1 µg/ml

Properties
Form Lyophilized
Storage Buffer lyophilized with PBS, pH 7.4, contains 0.02% sodium azide.
Reconstitution Reconstitute the lyophilized powder with deionized water (or equivalent) to an final concentration of 0.5 mg/mL.
Storage Instructions The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid freeze/thaw cycles.
Purification Protein A affinity column
Isotype Rabbit IgG
Clonality Monoclonal
Clone ID 137C6
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

Examples
  • MonoRab™ Anti-Rituximab Antibody (137C6), MAb, Rabbit
  • MonoRab™ Anti-Rituximab Antibody (137C6), MAb, Rabbit

    Anti-Rituximab Antibody (137C6), mAb, Rabbit (GenScript, A01942-40) binds with Rituximab. While the antibody does not recognize the human IgG Fc fragment (data not shown).
    Coating antigen: Rituximab, 1 µg/ml.
    Anti-Rituximab antibody (GenScript, A01942-40) dilution start from 1,000 ng/ml.
    EC₅₀= 12.17 ng/ml.

  • MonoRab™ Anti-Rituximab Antibody (137C6), MAb, Rabbit
  • MonoRab™ Anti-Rituximab Antibody (137C6), MAb, Rabbit

    Standard curve of Rituximab Sandwich ELISA. The Rituximab Sandwich ELISA assay is developed by using Anti-Rituximab Antibody (137C6), mAb, Rabbit (GenScript, A01942-40) and Anti-Rituximab Antibody (194D7) [Biotin], mAb, Rabbit (GenScript, A01944-40) as capture and detection antibody, respectively.
    The sensitivity of detecting Rituximab is about 30 pg/ml.


Background
Target Background Rituximab was approved for medical use in 1997. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, idiopathic thrombocytopenic purpura, pemphigus vulgaris and myasthenia gravis. Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. When it binds to this protein it triggers cell death.
Synonyms Rabbit monoclonal to Rituxan

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.